UK Markets close in 25 mins

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
220.04+2.86 (+1.32%)
As of 12:05PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close217.18
Open218.52
Bid220.73 x 1000
Ask221.01 x 1000
Day's range216.34 - 221.53
52-week range173.45 - 371.16
Volume244,666
Avg. volume1,361,867
Market cap34.612B
Beta (5Y monthly)1.13
PE ratio (TTM)51.41
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Why Is Seattle Genetics (SGEN) Up 24.6% Since Last Earnings Report?

    Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Motley Fool

    Buy This Magnificent Growth Stock Before It's Too Late

    Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential. Bionano's claim to fame is its laboratory analyzer device for optical genome mapping, which it calls the Saphyr.

  • Reuters

    Icahn urges Illumina to unwind Grail deal, pushes ahead on proxy fight

    In his second letter to Illumina shareholders this week, Icahn wrote the "only path forward is for Grail to be divested". Illumina said on Monday it will divest Grail, which it purchased in 2021, if it loses its appeal to the European Commission where regulators said last year they intend to require Illumina to unwind the $7.1 billion takeover. Icahn, who owns 1.4% of Illumina, launched a proxy fight earlier this week and is seeking three board seats at the company after weeks of private discussions with Illumina sputtered.